BioCentury
ARTICLE | Distillery Therapeutics

Increasing lung MFSD7C levels for hemolytic anemia

December 16, 2024 8:36 PM UTC

Increasing levels of the membrane transport protein MFSD7C could help treat hemolytic anemia by preventing lung endothelial cell and alveolar macrophage death via ferroptosis, reducing inflammation and fibrosis.

In a human lung endothelial cell line, exposure to heme to induce a hemolytic anemia phenotype decreased MFSD7C protein expression compared with vehicle. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article